RPWE-1 (10,000 cells/well) cell viability was not altered by daily treatment of testosterone (0.1 nM–30 nM), dihydrotestosterone (0.03 nM–100 nM), or mibolerone (0.01 nM–20 nM) after a 5-day treatment period; no significant treatment effects.
<p>RPWE-1 (10,000 cells/well) cell viability was not altered by daily treatment of testosterone (0.1 nM–30 nM), dihydrotestosterone (0.03 nM–100 nM), or mibolerone (0.01 nM–20 nM) after a 5-day treatment period; no significant treatment effects.</p
